Connecting the Dots: Diabetes, CKD, and CVD Pathways
CME
2
|
MOC
2
Connecting the Dots: Diabetes, CKD, and CVD Pathways

Connecting the Dots: Diabetes, CKD, and CVD Pathways enhances clinical understanding of the interconnected conditions of type 2 diabetes (T2D), chronic kidney disease (CKD), and cardiovascular disease (CVD). This FREE course strengthens recognition of shared pathophysiology, provides a framework for applying evidence-based risk assessment and treatment strategies, and will help improve care coordination through timely and appropriate referrals to drive better outcomes for patients with complex cardiometabolic conditions.

Activity format: enduring activity that includes case-based questions and an interactive branching scenario.

Register
2
CME
Starts

5/12/25

Expires

5/12/26

Learning Objectives

Upon successful completion of the program, participants should be better able to:

  • Explain the complex relationships between insulin resistance and CKD, discuss the underlying mechanisms driving CVD development and progression, and apply a comprehensive framework for risk stratification and prevention of CVD in patients with these comorbidities. 
  • Identify and apply evidence-based risk assessment strategies for CVD in patients with metabolic risk factors, hypertension, diabetes, CKD, or a combination of these, using tools such as risk calculators and biomarkers to facilitate early detection and timely intervention. 
  • Identify guideline-based treatment options for managing CVD in patients with metabolic disease, diabetes, and kidney disease, including lifestyle modifications, emerging and existing pharmacologic interventions such as sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1), anti-hypertensive therapies, and lipid-lowering agents, and digital health technologies. 
  • Apply clear referral criteria to identify patients requiring specialized care, ensuring timely and appropriate referrals to endocrinologists, cardiologists, nephrologists, and other specialists. 
Target Audience

U.S. healthcare professionals, focusing on primary care professions (PCPs), including physicians, nurse practitioners (NPs), physician assistants (PAs), and specialists such as endocrinologists, cardiologists, and nephrologists who manage patients with T2D, CKD, and CVD.

Speakers/Faculty

SPEAKERS
FACULTY

Samina Afreen, MD, FOMA
Endocrinologist
UVA Health
Charlottesville, VA

Joseph Aloi, MD, FACE, FACP
Professor Of Medicine
Chief Endocrinology & Metabolism
Wake Forest University School of Medicine
Winston-Salem, NC

Mayra Cantazaro, DNP, APRN, FNP-BC, BC-ADM, CDCES
Assistant Professor
UTRGV-SON: Doctor of Nursing Practice Program
Valley Diabetes & Endocrinology Comprehensive Center (VDECC)
Edinburg, TX

Pranjali Sharma, MD, DABOM,FACE, FAPCR, FEAA
Endocrinologist
Scripps Clinic Division of Diabetes & Endocrinology
La Jolla, CA

Commercial Support

This activity is supported by independent educational grants from Abbott Diabetes Care.